# AMOXICILLIN AND CLAVULANATE POTASSIUM
> **ANDA210374** · Abbreviated New Drug Application (Generic) · Sponsor: DEVA HOLDING AS · Approved 2023-11-29
## Drug
- **FDA Application Number:** ANDA210374
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** AMOXICILLIN AND CLAVULANATE POTASSIUM
- **Generic name:** AMOXICILLIN AND CLAVULANATE POTASSIUM
- **Active ingredients:** AMOXICILLIN; CLAVULANATE POTASSIUM
- **Dosage form:** FOR SUSPENSION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** DEVA HOLDING AS
- **Manufacturer:** Devatis, Inc.
- **First approval:** 2023-11-29
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210374)
---
*AI Analytics · CC0 1.0*